Document is current
Any future updates will be listed below
-
Authors
Broekaart, Diede W. M.
Sharma, Abhijeet
Ramakrishnan, Aarthi
Chongtham, Anjalika
Günther, Dorothee M.
Subramaniyan, Saraswathi
Wang, Minghui
Patel, Vishwendra
Zhang, Bin
Grinberg, Lea T.
Blitzer, Robert D.
Schmidt, Eric F.
Shen, Li
Hof, Patrick R.
Pereira, Ana C.
-
Funding
Funding for this research was provided by:
National Institutes of Health, United States (P01 AG019724)
Consortium for Frontotemporal Dementia Research
Tau Consortium
National Institutes of Health,United States (P30 AG066514, R01 AG064020)
National Institutes of Health (R01 AG063819)
Dana Foundation
BrightFocus Foundation
Alzheimer's Association
Karen Strauss Cook Research Scholar Award
Carolyn and Eugene Mercy Research Gift
Alzheimer’s New Jersey
Robert J. and Claire Pasarow Foundation
Judith and Marvin Herb Family
- License Information
-
More Information
Article History
Received: 19 September 2024
Revised: 11 April 2025
Accepted: 12 April 2025
First Online: 7 June 2025
Declarations
:
: ACP has patents related to riluzole licensed to Neurobiopharma, LLC (unrelated to this work), serves on the scientific advisory board of Sinaptica Therapeutics and Tau Biosciences and has served as a consultant to Eisai and Quanterix.
